2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street
Don’t get too excited about their prospects.
Intellia Therapeutics (NTLA 4.13%) and Iovance Biotherapeutics (IOVA 3.16%) are relatively innovative biotech companies. However, due to company-specific headwinds, both have seen their shares lag the market significantly this year.
» Read more about: 2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street »